Suppr超能文献

用于评估化合物毒性的人肾近端小管上皮细胞的开发与应用

Development and Application of Human Renal Proximal Tubule Epithelial Cells for Assessment of Compound Toxicity.

作者信息

Li Shuaizhang, Zhao Jinghua, Huang Ruili, Steiner Toni, Bourner Maureen, Mitchell Michael, Thompson David C, Zhao Bin, Xia Menghang

机构信息

9800 Medical Center Drive, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, MD 20892-3375, USA.

Sigma-Aldrich Corporation, St. Louis, MO 63103, USA.

出版信息

Curr Chem Genom Transl Med. 2017 Feb 14;11:19-30. doi: 10.2174/2213988501711010019. eCollection 2017.

Abstract

Kidney toxicity is a major problem both in drug development and clinical settings. It is difficult to predict nephrotoxicity in part because of the lack of appropriate cell models, limited endpoints, and the observation that the activity of membrane transporters which plays important roles in nephrotoxicity by affecting the pharmacokinetic profile of drugs is often not taken into account. We developed a new cell model using pseudo-immortalized human primary renal proximal tubule epithelial cells. This cell line (SA7K) was characterized by the presence of proximal tubule cell markers as well as several functional properties, including transporter activity and response to a few well-characterized nephrotoxicants. We subsequently evaluated a group of potential nephrotoxic compounds in SA7K cells and compared them to a commonly used human immortalized kidney cell line (HK-2). Cells were treated with test compounds and three endpoints were analyzed, including cell viability, apoptosis and mitochondrial membrane potential. The results showed that most of the known nephrotoxic compounds could be detected in one or more of these endpoints. There were sensitivity differences in response to several of the chemicals between HK-2 and SA7K cells, which may relate to differences in expressions of key transporters or other components of nephrotoxicity pathways. Our data suggest that SA7K cells appear as promising for the early detection of renal toxicants.

摘要

肾毒性在药物研发和临床环境中都是一个主要问题。预测肾毒性很困难,部分原因是缺乏合适的细胞模型、有限的终点指标,以及人们发现,在肾毒性中通过影响药物药代动力学特征发挥重要作用的膜转运蛋白活性常常未被考虑在内。我们利用伪永生化的人原代肾近端小管上皮细胞开发了一种新的细胞模型。该细胞系(SA7K)的特征是存在近端小管细胞标志物以及若干功能特性,包括转运蛋白活性和对几种特征明确的肾毒物的反应。我们随后在SA7K细胞中评估了一组潜在的肾毒性化合物,并将它们与常用的人永生化肾细胞系(HK - 2)进行比较。用测试化合物处理细胞,并分析三个终点指标,包括细胞活力、凋亡和线粒体膜电位。结果表明,大多数已知的肾毒性化合物可以在这些终点指标中的一个或多个中被检测到。HK - 2细胞和SA7K细胞对几种化学物质的反应存在敏感性差异,这可能与关键转运蛋白或肾毒性途径其他成分的表达差异有关。我们的数据表明,SA7K细胞在早期检测肾毒物方面似乎很有前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d623/5362976/1f3456c29d4b/CCGTM-11-19_F1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验